인진오령산의 알콜성 간염에 미치는 영향
Effects of Injinoryung-San on Alcoholic Hepatitis
0
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
This study was performed to investigate the effect of the extracts from Injinoryng-San on liver injury patients induced by alcohol. Injinoryung-San was recorded the drug for jaundice at Hwang-Je-Nae-Kyung. Twenty-seven patients who have intaked alcohol above 40 g, every day, 5 years, twenty-seventy ages were selected. After take a written consent, we divide them into experimental groups and control groups by double blind test. Each groups was evaluated every 2 weeks(2,4,6 weeks). After 2 weeks, Injinoryung-San groups significantly decreased GGT in comparison with control groups(p<0.05). After 4 weeks, Injinoryung-San groups significantly decreased MCV, GGT in comparison with control groups(p<0,05). After 6 weeks, Injinoryung-San groups significantly decreased MCV in comparison with control groups(p<0.05). Reviewing these experimental results, it appears that extracts of Injinoryung-San have pharmaceutical efficacy in GGT, MCV on liver injury patients induced by alcohol. But it has not efficacy in AST, ALT. According to drinking alcohol has becomes social problems, we should effort to make efficacious oriental medicines on alcoholic hepatitis.
Abstract
This study was performed to investigate the effect of the extracts from Injinoryng-San on liver injury patients induced by alcohol. Injinoryung-San was recorded the drug for jaundice at Hwang-Je-Nae-Kyung. Twenty-seven patients who have intaked alcohol above 40 g, every day, 5 years, twenty-seventy ages were selected. After take a written consent, we divide them into experimental groups and control groups by double blind test. Each groups was evaluated every 2 weeks(2,4,6 weeks). After 2 weeks, Injinoryung-San groups significantly decreased GGT in comparison with control groups(p<0.05). After 4 weeks, Injinoryung-San groups significantly decreased MCV, GGT in comparison with control groups(p<0,05). After 6 weeks, Injinoryung-San groups significantly decreased MCV in comparison with control groups(p<0.05). Reviewing these experimental results, it appears that extracts of Injinoryung-San have pharmaceutical efficacy in GGT, MCV on liver injury patients induced by alcohol. But it has not efficacy in AST, ALT. According to drinking alcohol has becomes social problems, we should effort to make efficacious oriental medicines on alcoholic hepatitis.
참고문헌 (18)
- 변관수, "알콜성 간질환의 임상적 특징과 내과적 관리", 대한간학회지, 통권 : 2, pp.73~78 (2002)
- 이창홍, "만성간질환", 대한소화기 학회 세미나, 통권 : 14, pp.56~62 (2002)
- Kim, Y.S., "The prognosis of Liver cirrhosis in recent years in korea", J korean Med Sci, 18, pp.883~841 (2003)
- 서광식, "최근 5년간 간경변의 원인과 합병증에 관한 고찰", 대한간학회지, 3, pp.202~209 (1997)
- 양항미, "中醫肝病診療常規", pp.129~133 (2005), 상해과기교육출판사
- 권상욱, "알콜성 간질환의 치료", 대한간학회지, 7(1), pp.71~78
- 郭維加, "新編國家中成藥", pp.1033~ (2002), 人民衛生出版社
- 김호현, "인진오령산이 흰쥐의 신독성에 미치는 영향", 대한한의학회지, 17(2), pp.113~144 (1996)
- 곽섭, "위령탕및 인진오령산이 Galactosamine 에 의한 백서의 간손상에 미치는 영향", 원광한의학, 3(1), pp.81~97 (1993)
- 김용정, "長期間의 茵陳五령散 투여가 肝機能에 미치는 영향", 동의생리병리학회지, 18(6), pp.1908~1912 (2004), 대한동의병리학회
- Menon, K.V., "Pathogenesis, diagnosis and treatment of alcoholic liver disease", Mayo Clin Proc, 76, pp.1021~1029 (2001)
- Maher, J.J., "Treatment of alcoholic hepatitis", J Gastroenterol Hepatol, 17, pp.448~455 (2002)
- 정재윤, "한국인 알코올 간염 환자의 예후 판정을 위한 Discriminant Function 점수, Child-Turcotte-Pugh 점수와 Model for End-stage Liver Disease 점수 비교", 대한소화기학회지, 49(2), pp.93~99 (2007), 대한소화기학회
- 대한소화기학회, "간염(2nd Edition)", pp.219~231 (2005), 군자출판사
- 곽재용, "알콜성 간질환에 대한 임상적 연구", 전북의대논문집, 19(1), pp.69~79 (1995)
- 홍상훈, "과음하는 성인남자 53 명의 음주패턴과 간 장애에 대한 분석 연구", 대한한방내과학회지, 28(1), pp.115~123 (2007), 대한한방내과학회
- 홍상훈, "알콜성 간질환에 대한 고찰과 증례 보고", 대한침구학회지, 16(3), pp.15~24 (1999)
- 周現武, "祛濕消瘀湯治療酒精性肝炎 45例", 四川中醫, 25(1), pp.63~ (2007)